These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 16959370)

  • 1. Differential expression of STAT5 and Bcl-xL, and high expression of Neu and STAT3 in non-small-cell lung carcinoma.
    Sánchez-Ceja SG; Reyes-Maldonado E; Vázquez-Manríquez ME; López-Luna JJ; Belmont A; Gutiérrez-Castellanos S
    Lung Cancer; 2006 Nov; 54(2):163-8. PubMed ID: 16959370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estimation of prognostic value of Bcl-xL gene expression in non-small cell lung cancer.
    Karczmarek-Borowska B; Filip A; Wojcierowski J; Smoleń A; Korobowicz E; Korszen-Pilecka I; Zdunek M
    Lung Cancer; 2006 Jan; 51(1):61-9. PubMed ID: 16297499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of phosphorylated Stat3, cyclin D1 and Bcl-xL in extramammary Paget disease.
    Liu HJ; Moroi Y; Masuda T; Yasumoto S; Kokuba H; Imafuku S; Koga T; Tetsuya T; Tu YT; Aburatani H; Furue M; Urabe K
    Br J Dermatol; 2006 May; 154(5):926-32. PubMed ID: 16634897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frequent high expression of bax pro-apoptotic protein in non-small cell lung cancer.
    Caputi M; Groeger AM; Esposito V; De Luca A; Murabito M; Tahir T; Giordano GG; Baldi F; Giordano A; Wolner E
    Anticancer Res; 1999; 19(1B):825-7. PubMed ID: 10216500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of MDA-7/IL-24 and its clinical significance in resected non-small cell lung cancer.
    Ishikawa S; Nakagawa T; Miyahara R; Kawano Y; Takenaka K; Yanagihara K; Otake Y; Katakura H; Wada H; Tanaka F
    Clin Cancer Res; 2005 Feb; 11(3):1198-202. PubMed ID: 15709189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prognostic value of expression of FASE, HER-2/neu, bcl-2 and p53 in stage I non-small cell lung cancer].
    Wang Y; Zhang XR; Fu J; Tan W; Zhang W
    Zhonghua Zhong Liu Za Zhi; 2004 Jun; 26(6):369-72. PubMed ID: 15312350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of Stat3 activation and tumor growth suppression of non-small cell lung cancer by G-quartet oligonucleotides.
    Weerasinghe P; Garcia GE; Zhu Q; Yuan P; Feng L; Mao L; Jing N
    Int J Oncol; 2007 Jul; 31(1):129-36. PubMed ID: 17549413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of constitutively active signal transducer and activator of transcription 3 in ovarian tumorigenesis and prognosis.
    Rosen DG; Mercado-Uribe I; Yang G; Bast RC; Amin HM; Lai R; Liu J
    Cancer; 2006 Dec; 107(11):2730-40. PubMed ID: 17063503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Expression and clinical significance of COX-2, p-Stat3, and p-Stat5 in esophageal carcinoma].
    Liu JR; Wang Y; Zuo LF; Li FL; Wang Y; Liu JL
    Ai Zheng; 2007 May; 26(5):458-62. PubMed ID: 17672932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of PTEN and FHIT is involved in regulating the balance between apoptosis and proliferation in lung carcinomas.
    Zheng H; Tsuneyama K; Takahashi H; Miwa S; Nomoto K; Saito H; Masuda S; Takano Y
    Anticancer Res; 2007; 27(1B):575-81. PubMed ID: 17348444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiapoptotic activity of autocrine interleukin-22 and therapeutic effects of interleukin-22-small interfering RNA on human lung cancer xenografts.
    Zhang W; Chen Y; Wei H; Zheng C; Sun R; Zhang J; Tian Z
    Clin Cancer Res; 2008 Oct; 14(20):6432-9. PubMed ID: 18927282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bcl-2 protein expression correlates with nodal status in non small cell lung cancer.
    Groeger AM; Caputi M; Esposito V; De Luca A; Salat A; Murabito M; Giordano GG; Baldi F; Giordano A; Wolner E
    Anticancer Res; 1999; 19(1B):821-4. PubMed ID: 10216499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phospho-Stat3 expression and correlation with VEGF, p53, and Bcl-2 in gastric carcinoma using tissue microarray.
    Choi JH; Ahn MJ; Park CK; Han HX; Kwon SJ; Lee YY; Kim IS
    APMIS; 2006 Sep; 114(9):619-25. PubMed ID: 16948814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Nuclear factor-kappaB activity and its correlation with cell proliferation in non-small cell lung cancer tissues].
    Zhang J; Xu YJ; Zhang ZX; DU CL; Qiao LF; Ni W; Chen SX
    Zhonghua Jie He He Hu Xi Za Zhi; 2007 Oct; 30(10):771-5. PubMed ID: 18218209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sex-specific survival advantage with parathyroid hormone-related protein in non-small cell lung carcinoma patients.
    Hastings RH; Laux AM; Casillas A; Xu R; Lukas Z; Ernstrom K; Deftos LJ
    Clin Cancer Res; 2006 Jan; 12(2):499-506. PubMed ID: 16428492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effects of STAT3 antisense oligonucleotide on proliferation and apoptosis of non-small cell lung cancer cell line A549].
    Zhu BR; Cai JM; Tang GS; Li BL; Gao F; Cui JG; Liu HC
    Ai Zheng; 2007 Aug; 26(8):820-7. PubMed ID: 17697540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stem-cell protein Piwil2 is widely expressed in tumors and inhibits apoptosis through activation of Stat3/Bcl-XL pathway.
    Lee JH; Schütte D; Wulf G; Füzesi L; Radzun HJ; Schweyer S; Engel W; Nayernia K
    Hum Mol Genet; 2006 Jan; 15(2):201-11. PubMed ID: 16377660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of axin downregulates TCF-4 and inhibits the development of lung cancer.
    Xu HT; Wei Q; Liu Y; Yang LH; Dai SD; Han Y; Yu JH; Liu N; Wang EH
    Ann Surg Oncol; 2007 Nov; 14(11):3251-9. PubMed ID: 17768662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of FOXP3 expression with non-small cell lung cancer.
    Dimitrakopoulos FI; Papadaki H; Antonacopoulou AG; Kottorou A; Gotsis AD; Scopa C; Kalofonos HP; Mouzaki A
    Anticancer Res; 2011 May; 31(5):1677-83. PubMed ID: 21617226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. L-type amino acid transporter 1 expression is a prognostic marker in patients with surgically resected stage I non-small cell lung cancer.
    Imai H; Kaira K; Oriuchi N; Yanagitani N; Sunaga N; Ishizuka T; Kanai Y; Endou H; Nakajima T; Mori M
    Histopathology; 2009 Jun; 54(7):804-13. PubMed ID: 19635099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.